Paraquat induces cyclooxygenase-2 (COX-2) implicated toxicity in human neuroblastoma SH-SY5Y cells

Toxicology Letters

Volumn 199, Issue 3, 2010, Pages 239-246

  Yang, Wonsuk ^a   Tiffany Castiglioni, Evelyn ^b   Lee, Mi Young ^c   Son, Il Hong ^a  

^a Wonkwang University   (South Korea)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Soonchunhyang University   (South Korea)

Author keywords

COX 2; DJ 1; Nrf2; Paraquat; Parkinson's disease; SY5Y

Indexed keywords

CYCLOOXYGENASE 2; DJ 1 PROTEIN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELOXICAM; MESSENGER RNA; PARAQUAT; QUINONE DERIVATIVE; TRANSCRIPTION FACTOR NRF2;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELL LINE, TUMOR; CELL SURVIVAL; CYCLOOXYGENASE 2; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HERBICIDES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; L-LACTATE DEHYDROGENASE; NEUROBLASTOMA; NF-E2-RELATED FACTOR 2; NF-KAPPA B; ONCOGENE PROTEINS; PARAQUAT; QUINONES;

EID: 78650515554     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.09.005     Document Type: Article

References (75)

1. Alvarez S., Blanco A., Fresno M., Muñoz-Fernández M.A. Nuclear factor-kappaB activation regulates cyclooxygenase-2 induction in human astrocytes in response to CXCL12: role in neuronal toxicity. J. Neurochem. 2010, 113:772-783.
2. Appleby S.B., Ristimäki A., Neilson K., Norko K., Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem. J. 1994, 302:723-727.
3. Batelli S., Albani D., Rametta R., Polito L., Prato F., Pesaresi M., Negro A., Forloni G. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70. PLoS One 2008, 3:e1884.
4. Bagh M.B., Maiti A.K., Jana S., Banerjee K., Roy A., Chakrabarti S. Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson's disease. Free Radic. Res. 2008, 42:574-581.
5. Bharath S., Hsu M., Kaur D., Rajagopalan S., Andersen J.K. Glutathione, iron and Parkinson's disease. Biochem. Pharmacol. 2002, 64:1037-1048.
6. Brown T.P., Rumsby P.C., Capleton A.C., Rushton L., Levy L.S. Pesticides and Parkinson's disease - is there a link?. Environ. Health Perspect. 2006, 114:156-164.
7. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 1983, 80:4546-4550.
8. Canet-Avilés R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., Cookson M.R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. USA 2004, 101:9103-9108.
9. Carrasco E., Casper D., Werner P. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity. J. Neurosci. Res. 2007, 85:3109-3117.
10. Casciati A., Ferri A., Cozzolino M., Celsi F., Nencini M., Rotilio G., Carrì M.T. Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases. J. Neurochem. 2002, 83:1019-1029.
11. Castello P.R., Drechsel D.A., Patel M. Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J. Biol. Chem. 2007, 282:14186-14193.
12. Chae S.W., Bang Y.J., Kim K.M., Lee K.Y., Kang B.Y., Kim E.M., Inoue H., Hwang O., Choi H.J. Role of cyclooxygenase-2 in tetrahydrobiopterin-induced dopamine oxidation. Biochem. Biophys. Res. Commun. 2007, 359:735-741.
13. Chae S.W., Kang B.Y., Hwang O., Choi H.J. Cyclooxygenase-2 is involved in oxidative damage and alpha-synuclein accumulation in dopaminergic cells. Neurosci. Lett. 2008, 36:205-209.
14. Choi J., Sullards M.C., Olzmann J.A., Rees H.D., Weintraub S.T., Bostwick D.E., Gearing M., Levey A.I., Chin L.S., Li L. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 2006, 281:10816-10824.
15. Clements C.M., McNally R.S., Conti B.J., Mak T.W., Ting J.P. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. USA 2006, 103:15091-15096.
16. Copple I.M., Goldring C.E., Kitteringham N.R., Park B.K. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 2008, 246:24-33.
17. Costello S., Cockburn M., Bronstein J., Zhang X., Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am. J. Epidemiol. 2009, 169:919-926.
18. Dinis-Oliveira R.J., Remião F., Carmo H., Duarte J.A., Navarro A.S., Bastos M.L., Carvalho F. Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology 2006, 27:1110-1122.
19. Fiebich B.L., Mueksch B., Boehringer M., Hüll M. Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. J. Neurochem. 2000, 75:2020-2028.
20. Franklin C.C., Rosenfeld-Franklin M.E., White C., Kavanagh T.J., Fausto N. TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms. FASEB J. 2003, 17:1535-1537.
21. Ghosh A., Roy A., Liu X., Kordower J.H., Mufson E.J., Hartley D.M., Ghosh S., Mosley R.L., Gendelman H.E., Pahan K. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 2007, 104:18754-18759.
22. Griffith O.W. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med. 1999, 27:922-935.
23. Han J.M., Lee Y.J., Lee S.Y., Kim E.M., Moon Y., Kim H.W., Hwang O. Protective effect of sulforaphane against dopaminergic cell death. J. Pharmacol Exp. Ther. 2007, 321:249-256.
24. Hastings T.G. Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J. Neurochem. 1995, 64:919-924.
25. Hughes J.T. Brain damage due to paraquat poisoning: a fatal case with neuropathological examination of the brain. Neurotoxicology 1988, 9:243-248.
26. Hulleman J.D., Mirzaei H., Guigard E., Taylor K.L., Ray S.S., Kay C.M., Regnier F.E., Rochet J.C. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease. Biochemistry 2007, 46:5776-5789.
27. Jang J.H., Surh Y.J. Beta-amyloid-induced apoptosis is associated with cyclooxygenase-2 up-regulation via the mitogen-activated protein kinase-NF-kappaB signaling pathway. Free Radic. Biol. Med. 2005, 38:1604-1613.
28. Kaltschmidt B., Linker R.A., Deng J., Kaltschmidt C. Cyclooxygenase-2 is a neuronal target gene of NF-kappaB. BMC Mol. Biol. 2002, 3:16.
29. Kuhn D.M., Arthur R.E., Thomas D.M., Elferink L.A. Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease. J. Neurochem. 1999, 73:1309-1317.
30. Kuter K., Smiałowska M., Wierońska J., Zieba B., Wardas J., Pietraszek M., Nowak P., Biedka I., Roczniak W., Konieczny J., Wolfarth S., Ossowska K. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Res. 2007, 1155:196-207.
31. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. 1998, 70:452-466.
32. Langston J.W., Forno L.S., Tetrud J., Reeves A.G., Kaplan J.A., Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropryidine exposure. Ann. Neurol. 1999, 46:598-605.
33. LaVoie M.J., Ostaszewski B.L., Weihofen A., Schlossmacher M.G., Selkoe D.J. Dopamine covalently modifies and functionally inactivates parkin. Nat. Med. 2005, 11:1214-1221.
34. Lee H.J., Bazinet R.P., Rapoport S.I., Bhattacharjee A.K. Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson disease. Neurochem. Res. 2010, 35:613-619.
35. Levites Y., Youdim M.B., Maor G., Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem. Pharmacol. 2002, 63:21-29.
36. Li L.Y., Zhao X.L., Fei X.F., Gu Z.L., Qin Z.H., Liang Z.Q. Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra. Acta Pharmacol. Sin. 2008, 29:539-547.
37. Liang X., Wu L., Wang Q., Hand T., Bilak M., McCullough L., Andreasson K. Function of COX-2 and prostaglandins in neurological disease. J. Mol. Neurosci. 2007, 33:94-99.
38. Lin Y.C., Uang H.W., Lin R.J., Chen I.J., Lo Y.C. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells. J Pharmacol. Exp. Ther. 2007, 323:877-887.
39. Liou H.H., Chen R.C., Tsai Y.F., Chen W.P., Chang Y.C., Tsai M.C. Effects of paraquat on the substantia nigra of the Wistar rats: neurochemical, histological, and behavioral studies. Toxicol. Appl. Pharmacol. 1996, 137:34-41.
40. Litteljohn D., Mangano E.N., Hayley S. Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice. Eur. J. Neurosci. 2008, 28:707-716.
41. Madeley, J. 2002. Paraquat-Syngenta's controversial herbicide. A written report for Berne Declaration, Swedish Society for Nature conservation, Pesticide Action Network UK, Pesticide Action Network Asia Pacific, and Foro Emaús. 1-28.
42. Malhotra D., Thimmulappa R., Navas-Acien A., Sandford A., Elliott M., Singh A., Chen L., Zhuang X., Hogg J., Pare P., Tuder R.M., Biswal S. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator 2008, DJ-1.
43. Manabe Y., Anrather J., Kawano T., Niwa K., Zhou P., Ross M.E., Iadecola C. Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity. Ann. Neurol. 2004, 55:668-675.
44. Manning-Bog A.B., McCormack A.L., Li J., Uversky V.N., Fink A.L., Di Monte D.A. The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice. J. Biol. Chem. 2002, 277:1641-1644.
45. Mattammal M.B., Strong R., Lakshmi V.M., Chung H.D., Stephenson A.H. Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease. J. Neurochem. 1995, 64:1645-1654.
46. McCormack A.L., Atienza J.G., Johnston L.C., Andersen J.K., Vu S., Di Monte D.A. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem. 2005, 93:1030-1037.
47. Miyazaki I., Asanuma M. Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochem. Res. 2009, 34:698-706.
48. Miyazaki I., Asanuma M., Diaz-Corrales F.J., Fukuda M., Kitaichi K., Miyoshi K., Ogawa N. Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules. FASEB J. 2006, 20:571-573.
49. Narita M., Shimamura M., Imai S., Kubota C., Yajima Y., Takagi T., Shiokawa M., Inoue T., Suzuki M., Suzuki T. Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice. Neuroscience 2008, 152:477-486.
50. Nunome K., Miyazaki S., Nakano M., Iguchi-Ariga S., Ariga H. Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol. Pharm. Bull. 2008, 31:1321-1326.
51. O'Banion M.K. Cycoloxygenase-2: molecular biology, pharmacology, and neurobiology. Crit. Rev. Neurobiol. 1999, 13:45-82.
52. Ortiz-Ortiz M.A., Morán J.M., Bravosanpedro J.M., González-Polo R.A., Niso- Santano M., Anantharam V., Kanthasamy A.G., Soler G., Fuentes J.M. Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species. Neurotoxicology 2009, 30:1008-1018.
53. Panet H., Barzilai A., Daily D., Melamed E., Offen D. Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells. J. Neurochem. 2001, 77:391-398.
54. Park S.H., Choi W.S., Yoon S.Y., Ahn Y.S., Oh Y.J. Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+-induced dopaminergic neuronal cell death: its potential role as a survival determinant. Biochem. Biophys. Res. Commun. 2004, 322:727-733.
55. Paz M.A., Flückiger R., Boak A., Kagan H.M., Gallop P.M. Specific detection of quinoproteins by redox-cycling staining. J. Biol. Chem. 1991, 266:689-692.
56. Pearce R.K., Owen A., Daniel S., Jenner P., Marsden C.D. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural Transm. 1997, 104:661-677.
57. Prasad K., Tarasewicz E., Mathew J., Strickland P.A., Buckley B., Richardson J.R., Richfield E.K. Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain. Exp. Neurol. 2009, 215:358-367.
58. Prasad K., Winnik B., Thiruchelvam M.J., Buckley B., Mirochnitchenko O., Richfield E.K. Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain. Environ. Health Perspect. 2007, 115:1448-1453.
59. Ramsey C.P., Glass C.A., Montgomery M.B., Lindl K.A., Ritson G.P., Chia L.A., Hamilton R.L., Chu C.T., Jordan-Sciutto K.L. Expression of Nrf2 in neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 2007, 66:75-85.
60. Tamura M., Sebastian S., Gurates B., Yang S., Fang Z., Bulun S.E. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. J. Clin. Endocrinol. Metab. 2002, 87:3504-3507.
61. Teismann P., Ferger B. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease. Synapse 2001, 39:167-174.
62. Teismann P., Tieu K., Choi D.K., Wu D.C., Naini A., Hunot S., Vila M., Jackson- Lewis V., Przedborski S. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. USA 2003, 100:5473-5478.
63. Thomas D.M., Kuhn D.M. Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity. J. Pharmacol. Exp. Ther. 2005, 313:870-876.
64. United States Environmental Protection Agency. 1997. Paraquat dichloride. EPA-738-F-96-018.
65. Van Laar V.S., Mishizen A.J., Cascio M., Hastings T.G. Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol. Dis. 2009, 34:487-500.
66. Vijitruth, R., Liu, M., Choi, D.Y., Nguyen, X.V., Hunter, R.L., Bing, G., 2006. Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. J Neuroinflammation. 27, 3:6.
67. Whitehead R.E., Ferrer J.V., Javitch J.A., Justice J.B. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. J. Neurochem. 2001, 76:1242-1251.
68. Xie H.R., Hu L.S., Li G.Y. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin. Med. J. 2010, 123:1086-1092.
69. Xu R., Huang X., Kramer K.J., Hawley M.D. Characterization of products from the reactions of dopamine quinone with N-acetylcysteine. Bioorg. Chem. 1996, 24:110-126.
70. Yang W., Chen L., Ding Y., Zhuang X., Kang U.J. Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice. Hum. Mol. Genet. 2007, 16:2900-2910.
71. Yang W., Tiffany-Castiglioni E. The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. J. Toxicol. Environ. Health A 2005, 68:1939-1961.
72. Yang W., Tiffany-Castiglioni E. The bipyridyl herbicide paraquat induces proteasome dysfunction in human neuroblastoma SH-SY5Y cells. J. Toxicol. Environ. Health A. 2007, 70:1849-1857.
73. Yang W., Tiffany-Castiglioni E., Koh H.C., Son I.H. Paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. Toxicol. Lett. 2009, 191:203-210.
74. Zhang D., Zhang J.J., Liu G.T. The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells. Eur. J. Pharmacol. 2007, 30:1-6.
75. Zhou W., Freed C.R. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J. Biol. Chem. 2005, 280:43150-43158.